Total synthesis of optically active chanoclavine-I

Tetrahedron Letters

Volumn 37, Issue 52, 1996, Pages 9309-9312

  Yokoyama, Yuusaku ^a   Kondo, Kazuhiro ^a   Mitsuhashi, Masako ^a   Murakami, Yasuoki ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHANOCLAVINE 1; ERGOT ALKALOID; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DRUG SYNTHESIS; REACTION ANALYSIS;

EID: 0030599677     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)82950-4     Document Type: Article

References (26)

1. 1. Synthetic Studies on Indole and Related Compounds. Part 42. Part 41 : "A General Synthetic Route for 1-Substituted 4-Oxygenated β-Carbolines" Suzuki, H; Iwata(nee Miyagi), C; Sakurai, K.; Tokumoto, K.; Takahashi, H.; Hanada, M; Yokoyama, Y.; Murakami, Y. Tetrahedron, accepted.
2. 2 . Floss. H. G. Tetrahedron 1976, 32, 873-912.
3. 3 . a) Rebeck, J. Jr.; Tai, D. F.; Shue, Y.-K.J. Am. Chem. Soc., 1984, 106, 1813-1819.
4. b) Kogan, T. P.; Somers, T. C.; Vemuti, M. C. Tetrahedron, 1990, 46, 6623-6632.
5. c) Varie, D. L. Tetrahedron Lett., 1990, 31, 7583-7586.
6. d) Mascal, M.; Moody, C. J.; Slawin, A. M. Z.; Williams, D. J. J. Chem. Soc., Perkin Trans. I, 1992, 823-830.
7. e) Sommelhack, M. F.; Knochel, P.; Singleton, T. Tetrahedron Lett., 1993, 32, 5051-5054.
8. 4 . a) Yokoyama, Y.; Takahashi, M.; Kohno, Y.; Kataoka, K.; Fujikawa, Y.; Murakami, Y. Heterocycles 1990, 31, 803-804.
9. b) Yokoyama, Y.; Takahashi, M.; Higaki, C.; Shidori, K.; Moriguti, M.; Ando, C.; Murakami, M. Heterocycles, 1993, 36, 1739-1742.
10. c) Yokoyama, Y.; Takahashi, M.; Takashima, M.; Kohno, Y; Kobayashi, H.; Kataoka, K.; Shidori, K.; Murakami, Y. Chem. Pharm. Bull. 1994, 42, 832-838.
11. 5 . Yokoyama, Y.; Matsumoto, T.; Murakami, Y.J. Org. Chem., 1995, 60, 1486-1487.
12. 6 . Total synthesis of (±)-8 : a) Plieninger, H.; Schmalz, D. Chem. Ber., 1976, 109, 2140-2147.
13. b) Kozikowski, A. P.; Ishida, H.J. Am. Chem. Soc., 1980, 102, 4265-4267.
14. c) Natsume, M.; Muratake, H. Heterocycles, 1981, 16, 375-379.
15. d) Oppolzer, W.; Grayson, J. I.; Wegmann, H.; Urrea, M. Tetrahedron, 1983, 39, 3695-3705.
16. e) Somei, M.; Makita, Y.; Yamada, F. Chem. Pharm. Bull., 1986, 34, 948-950. Total synthesis of optically active (-)-8 : Kardos, N.; Genet, J.-P. Tetrahedron Asymmetry, 1994, 5, 1525-1533.
17. e) Somei, M.; Makita, Y.; Yamada, F. Chem. Pharm. Bull., 1986, 34, 948-950. Total synthesis of optically active (-)-8 : Kardos, N.; Genet, J.-P. Tetrahedron Asymmetry, 1994, 5, 1525-1533.
18. 7. The R configuration of 3, the opposite configuration to natural tryptophan, has to be used to obtain the same stereoisomer as natural product.
19. 5, and the optical purity was determined as 55% ee. by HPLC using a chiral column (Daicel Chiralcel OD, Hexane : EtOH = 50 : 1).
20. 9. The observation of NOE between vinylic proton at 6.73ppm and aromatic proton at 7.64ppm shows that the olefin geometry is Z-configuration.
21. 10. Nahm, S.; Weinreb, S. M. Tetrahedron Lett., 1981, 22, 3815-3818.
22. 11. Petasis, N. M.; Bzowej, E. I. J. Am. Chem. Soc., 1990, 112, 6392-6394.
23. 2NH = 200 : 1 : 0.3 for 17). This means that the conversion step (10 → 6) and cyclization step (6 → 7) did not cause racemization.
24. 13. Muratake, H.; Natsume, M. Heterocycles, 1989, 29, 783.
25. D=-240° (pyridine), mp 222 °C : Stauffacher, D.; Tscherter, H. Helv. Chemica Acta, 1964, 47, 2186-2194.
26. 15. Hornwell, D. C.; Nichols, P. D.; Ratcliffe, G. S.; Roberts, E.J. Org. Chem., 1994, 59, 4418-4423.